社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Lamie
IP属地：未知
+关注
帖子 · 11
帖子 · 11
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
Lamie
Lamie
·
2021-12-23
$THE HOUR GLASS LIMITED(AGS.SI)$
more share buyback yesterday...owner will push it up again
看
2,769
回复
1
点赞
点赞
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-12-22
$VENTURE CORPORATION LIMITED(V03.SI)$
just keep it for dividends, it is cash rich.
看
3,581
回复
1
点赞
点赞
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-12-22
$THE HOUR GLASS LIMITED(AGS.SI)$
lets test new high towards new year
看
2,808
回复
2
点赞
点赞
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-12-02
Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.
Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna 和辉瑞股票：随着奥密克戎蔓延，应该购买哪一个？</blockquote>
Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks
Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna 和辉瑞股票：随着奥密克戎蔓延，应该购买哪一个？</blockquote>
看
2,658
回复
评论
点赞
2
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-11-19
Nice
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S
Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>
看
2,283
回复
评论
点赞
7
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-11-18
Lets rock tonight
非常抱歉，此主贴已删除
看
2,751
回复
1
点赞
3
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-08-20
Wtf
Snowflake Drops Most in Five Months Amid Cautious Analyst Report By Esha Dey<blockquote>Esha Dey 发布谨慎的分析师报告，雪花降幅为五个月来最大</blockquote>
(Update: August 20, 2021 at 10:37 a.m. ET) (Aug 20) Snowflake shares drop as much as 11% on Friday,
Snowflake Drops Most in Five Months Amid Cautious Analyst Report By Esha Dey<blockquote>Esha Dey 发布谨慎的分析师报告，雪花降幅为五个月来最大</blockquote>
看
2,783
回复
1
点赞
2
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-07-15
Norm is earnings out SP drops but not sure about TSM
TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>台积电第二季度利润因芯片需求强劲增长 11%</blockquote>
Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring ho
TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>台积电第二季度利润因芯片需求强劲增长 11%</blockquote>
看
1,889
回复
评论
点赞
4
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-07-13
Good for financials
Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6 月份消费者价格指数上涨 5.4%，而预期为 5%</blockquote>
Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor D
Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6 月份消费者价格指数上涨 5.4%，而预期为 5%</blockquote>
看
1,968
回复
1
点赞
5
编组 21备份 2
分享
举报
Lamie
Lamie
·
2021-07-05
Let them short
Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>
Iceberg Research, a short seller,said they're shorting AMC Entertainment. AMC stock tumbled 10% in F
Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>
看
1,810
回复
评论
点赞
4
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3565499732569971","uuid":"3565499732569971","gmtCreate":1612080367627,"gmtModify":1612080367627,"name":"Lamie","pinyin":"lamie","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":3,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.07.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.29","exceedPercentage":"93.33%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":691485880,"gmtCreate":1640228049071,"gmtModify":1640228049141,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>more share buyback yesterday...owner will push it up again","listText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>more share buyback yesterday...owner will push it up again","text":"$THE HOUR GLASS LIMITED(AGS.SI)$more share buyback yesterday...owner will push it up again","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/691485880","isVote":1,"tweetType":1,"viewCount":2769,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691834800,"gmtCreate":1640163150399,"gmtModify":1640163150399,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/V03.SI\">$VENTURE CORPORATION LIMITED(V03.SI)$</a>just keep it for dividends, it is cash rich.","listText":"<a href=\"https://laohu8.com/S/V03.SI\">$VENTURE CORPORATION LIMITED(V03.SI)$</a>just keep it for dividends, it is cash rich.","text":"$VENTURE CORPORATION LIMITED(V03.SI)$just keep it for dividends, it is cash rich.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691834800","isVote":1,"tweetType":1,"viewCount":3581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691152769,"gmtCreate":1640153987583,"gmtModify":1640153987583,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>lets test new high towards new year","listText":"<a href=\"https://laohu8.com/S/AGS.SI\">$THE HOUR GLASS LIMITED(AGS.SI)$</a>lets test new high towards new year","text":"$THE HOUR GLASS LIMITED(AGS.SI)$lets test new high towards new year","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691152769","isVote":1,"tweetType":1,"viewCount":2808,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603247312,"gmtCreate":1638418786833,"gmtModify":1638419068422,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","listText":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","text":"Bntx not mentioned which actually made more money and has larger market share than Mrna. Rubbush analysts.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/603247312","repostId":"1119742422","repostType":4,"repost":{"id":"1119742422","kind":"news","pubTimestamp":1638368504,"share":"https://www.laohunote.com/m/news/1119742422?lang=zh_CN&edition=full","pubTime":"2021-12-01 22:21","market":"us","language":"en","title":"Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna 和辉瑞股票：随着奥密克戎蔓延，应该购买哪一个？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1119742422","media":"TheStreet","summary":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks ","content":"<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自从发现奥密克戎变种以来，对大流行的担忧又回来了，疫苗相关股票再次成为焦点。今天，我们仔细看看 Moderna 和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎再次引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.</p><p><blockquote>11 月 26 日星期五，奥密克戎消息传出后，股市遭到抛售。由于不确定性，标普500下跌 2%。为数不多的上涨股票之一是 Moderna 股票，该股在周五的交易时段上涨了 20%，而辉瑞公司的股票上涨幅度较小，为 2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的 COVID-19 疫苗制造商之间，我们评估了 Moderna 和辉瑞的股票，并问自己：在奥密克戎担忧挥之不去的情况下，哪一家更值得购买？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>目前，13 名分析师一致持有 Moderna 股票，平均目标价为 298 美元，这表明较当前水平下跌 17%。华尔街的评估表明，自 COVID-19 大流行以来，MRNA 的股价已上涨超过 1200%，因此股价可能已经领先于基本面。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>Piper Sandler 的 Edward Tenthoff 对 Moderna 股票进行了最新报道，他重申了买入建议，并根据奥密克戎新闻预测目标价为 348 美元。这位分析师认为，该公司已经为新变种的出现做好了准备，并且“非常适合快速交换新版本的尖峰抗原”来制造新的 COVID-19 疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的马修-哈里森（Matthew Harrison）一周前重申了对 MRNA 的中性评级，目标价为 313 美元。这位分析师提到，年底前公布的 Moderna 流感疫苗数据可能会成为该股的积极催化剂。如果结果积极，市场可能会预计长期流感和新冠疫苗收入约为 100 亿美元，从而使股价上涨 10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度购买，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，在 11 月份上涨之后，估值可能会变得薄弱。PFE 根据 13 份报告给出适度买入建议，平均目标价为 50 美元。</blockquote></p><p> JPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的克里斯-肖特（Chris Schott）将辉瑞公司的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然这位分析师认为该公司核心业务的上涨空间有限，但他不会对近期奥密克戎头条新闻中的股价上涨感到惊讶。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>关于 PFE 的最新消息来自瑞穗证券的 Vamil Divan。他对辉瑞股票持怀疑态度，认为下行风险为 16%。但据这位分析师称，奥密克戎可能会增加对辉瑞公司 COVID-19 疫苗的近期需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街迷因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>新冠肺炎疫苗制造商可能会在短期内自然受益于对奥密克戎的担忧。例如，自 2020 年 3 月 COVID-19 大流行开始以来，Moderna 的股价已上涨超过 1,200%，而辉瑞的股价同期上涨了 79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE性能。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞公司的市值比 Moderna 大得多，其市值为 3000 亿美元，而 Moderna 的市值为 1330 亿美元。两家公司都拥有强大的疫苗管道和技术，但 Moderna 可能会从当前的疫情中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为 MRNA 是对 COVID-19 发展的更好的短期押注。然而，出于同样的原因，并且由于 2023 年市盈率更高，为 32 倍，该股可能会更加波动并存在更高的下行风险。另一方面，PFE 可能是对整个医疗保健行业更好的长期押注，特别是考虑到 2023 年去风险市盈率仅为 13 倍。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna 和辉瑞股票：随着奥密克戎蔓延，应该购买哪一个？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna or Pfizer Stock: Which to Buy as Omicron Spreads?<blockquote>Moderna 和辉瑞股票：随着奥密克戎蔓延，应该购买哪一个？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-01 22:21</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.</p><p><blockquote>自从发现奥密克戎变种以来，对大流行的担忧又回来了，疫苗相关股票再次成为焦点。今天，我们仔细看看 Moderna 和辉瑞的股票。</blockquote></p><p> COVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.</p><p><blockquote>新冠肺炎继续困扰市场。新变种奥密克戎再次引发了全世界对新的健康和经济危机的担忧，因为人们对这种变种如何影响接种疫苗和未接种疫苗的人知之甚少。</blockquote></p><p> The stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.</p><p><blockquote>11 月 26 日星期五，奥密克戎消息传出后，股市遭到抛售。由于不确定性，标普500下跌 2%。为数不多的上涨股票之一是 Moderna 股票，该股在周五的交易时段上涨了 20%，而辉瑞公司的股票上涨幅度较小，为 2.5%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b55d87c377ec124bb84173bfb955b9fa\" tg-width=\"689\" tg-height=\"621\" width=\"100%\" height=\"auto\"><span>Figure 1: SPY, MRNA and PFE performance in the past 5-trading days.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图1：过去5个交易日的SPDR标普500指数ETF、MRNA和PFE表现。</span></p></blockquote></p><p> Between two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?</p><p><blockquote>在两家主要的 COVID-19 疫苗制造商之间，我们评估了 Moderna 和辉瑞的股票，并问自己：在奥密克戎担忧挥之不去的情况下，哪一家更值得购买？</blockquote></p><p> <b>Wall Street is neutral on Moderna</b></p><p><blockquote><b>华尔街对Moderna持中立态度</b></blockquote></p><p> Moderna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.</p><p><blockquote>目前，13 名分析师一致持有 Moderna 股票，平均目标价为 298 美元，这表明较当前水平下跌 17%。华尔街的评估表明，自 COVID-19 大流行以来，MRNA 的股价已上涨超过 1200%，因此股价可能已经领先于基本面。</blockquote></p><p> The most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.</p><p><blockquote>Piper Sandler 的 Edward Tenthoff 对 Moderna 股票进行了最新报道，他重申了买入建议，并根据奥密克戎新闻预测目标价为 348 美元。这位分析师认为，该公司已经为新变种的出现做好了准备，并且“非常适合快速交换新版本的尖峰抗原”来制造新的 COVID-19 疫苗。</blockquote></p><p> Morgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.</p><p><blockquote>摩根士丹利的马修-哈里森（Matthew Harrison）一周前重申了对 MRNA 的中性评级，目标价为 313 美元。这位分析师提到，年底前公布的 Moderna 流感疫苗数据可能会成为该股的积极催化剂。如果结果积极，市场可能会预计长期流感和新冠疫苗收入约为 100 亿美元，从而使股价上涨 10%。</blockquote></p><p> <b>Pfizer: moderate buy, but experts are skeptical</b></p><p><blockquote><b>辉瑞：适度购买，但专家持怀疑态度</b></blockquote></p><p> Wall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.</p><p><blockquote>根据股票评级，华尔街目前看好辉瑞。然而，平均价格目标共识表明，在 11 月份上涨之后，估值可能会变得薄弱。PFE 根据 13 份报告给出适度买入建议，平均目标价为 50 美元。</blockquote></p><p> JPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.</p><p><blockquote>摩根大通的克里斯-肖特（Chris Schott）将辉瑞公司的目标价从42美元上调至53美元，并维持中性评级。Covid仍然是辉瑞故事的焦点，Comirnaty和Paxlovid的销售额“将明显超出预期”。虽然这位分析师认为该公司核心业务的上涨空间有限，但他不会对近期奥密克戎头条新闻中的股价上涨感到惊讶。</blockquote></p><p> The most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.</p><p><blockquote>关于 PFE 的最新消息来自瑞穗证券的 Vamil Divan。他对辉瑞股票持怀疑态度，认为下行风险为 16%。但据这位分析师称，奥密克戎可能会增加对辉瑞公司 COVID-19 疫苗的近期需求，尤其是加强剂量。</blockquote></p><p> <b>Wall Street Memes’ take</b></p><p><blockquote><b>华尔街迷因的看法</b></blockquote></p><p> COVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.</p><p><blockquote>新冠肺炎疫苗制造商可能会在短期内自然受益于对奥密克戎的担忧。例如，自 2020 年 3 月 COVID-19 大流行开始以来，Moderna 的股价已上涨超过 1,200%，而辉瑞的股价同期上涨了 79%。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/198c43532bf2d097bc94e078b539a044\" tg-width=\"684\" tg-height=\"577\" width=\"100%\" height=\"auto\"><span>Figure 2: MRNA and PFE performance in the past 5-years.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图2：过去5年的MRNA和PFE性能。</span></p></blockquote></p><p> Pfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.</p><p><blockquote>辉瑞公司的市值比 Moderna 大得多，其市值为 3000 亿美元，而 Moderna 的市值为 1330 亿美元。两家公司都拥有强大的疫苗管道和技术，但 Moderna 可能会从当前的疫情中受益，因为它更像是一只纯粹的股票。</blockquote></p><p> Due to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.</p><p><blockquote>由于商业模式多元化，我们认为 MRNA 是对 COVID-19 发展的更好的短期押注。然而，出于同样的原因，并且由于 2023 年市盈率更高，为 32 倍，该股可能会更加波动并存在更高的下行风险。另一方面，PFE 可能是对整个医疗保健行业更好的长期押注，特别是考虑到 2023 年去风险市盈率仅为 13 倍。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://www.thestreet.com/memestocks/reddit-trends/moderna-or-pfizer-stock-which-to-buy-as-omicron-spreads","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1119742422","content_text":"Pandemic fears have returned since the discovery of the Omicron variant, and vaccine-related stocks are back in the spotlight. Today, we take a closer look at Moderna and Pfizer stocks.\nCOVID-19 keeps haunting the markets. New variant Omicron has renewed fears worldwide about a new health and economic crisis, since little is still known about how this variant affects vaccinated and non-vaccinated people.\nThe stock market sold off on Friday, November 26, after Omicron news hit the wire. The S&P 500 dropped 2% amid uncertainty. One of the few gainers was Moderna stock, which jumped 20% on Friday’s trading session, while Pfizer stock was up a more modest 2.5%.\nFigure 1: SPY, MRNA and PFE performance in the past 5-trading days.\nBetween two of the main COVID-19 vaccine makers, we assess Moderna and Pfizer stocks and ask ourselves: which is a better buy as Omicron fear lingers?\nWall Street is neutral on Moderna\nModerna stock currently has a hold consensus among 13 analysts and an average price target of $298, which suggests 17% downside from current levels. Wall Street’s assessment suggests that the stock price may have moved ahead of fundamentals, as MRNA has gained more than 1,200% since the COVID-19 pandemic started.\nThe most recent report on Moderna stock came from Piper Sandler’s Edward Tenthoff, who reiterated his buy recommendation and forecasted a $348 price target on the back of Omicron news. The analyst sees the company prepared for the emergence of new variants and \"ideally suited to rapidly swap in new versions of the Spike antigen\" to make new COVID-19 vaccines.\nMorgan Stanley’s Matthew Harrison reiterated his neutral rating on MRNA a week ago with a $313 price target. The analyst mentioned that the announcement of Moderna’s flu vaccine data before year-end could be a positive catalyst for the stock. If the results are positive, the market could price in about $10 billion in long-term flu and COVID vaccine revenue, bumping shares by 10%.\nPfizer: moderate buy, but experts are skeptical\nWall Street is currently bullish on Pfizer, based on stock ratings. However, average price target consensus suggests that valuations could be stretched thin, following the November rally. PFE has a moderate buy recommendation based on 13 reports and a $50 average price target.\nJPMorgan‘s Chris Schott raised the firm's price target on Pfizer to $53 from $42 and kept a neutral rating. Covid remains a focal point of the Pfizer story, and Comirnaty and Paxlovid sales are \"set to clearly exceed expectations”. While the analyst sees limited upside from the company's core business, he would not be surprised to see shares rally in the near-term on omicron headlines.\nThe most recent update on PFE came from Mizuho Securities’ Vamil Divan. He is skeptical on Pfizer stock and sees 16% downside risk. But according to the analyst, Omicron may increase near-term demand for Pfizer’s COVID-19 vaccine, especially for booster doses.\nWall Street Memes’ take\nCOVID-19 vaccine makers may naturally benefit in the near-term from Omicron fears. Moderna, for instance, has risen more than 1,200% since the beginning of the COVID-19 pandemic in March 2020, while Pfizer stock has climbed 79% during the same period.\nFigure 2: MRNA and PFE performance in the past 5-years.\nPfizer is much larger than Moderna, with a market cap size of $300 billion compared to Moderna’s $133 billion. Both companies have strong vaccine pipelines and technology, but Moderna likely benefits from the current pandemic for being more of a pure-play stock.\nDue to business model diversification, we see MRNA as a better short-term bet on COVID-19 developments. However, for this same reason and due to richer 2023 P/E of 32x, the stock is likely to be more volatile and present higher downside risk. PFE, on the other hand, could be a better long-term bet on healthcare at large, especially considering de-risked 2023 P/E of only 13x.","news_type":1,"symbols_score_info":{"MRNA":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":2658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876590686,"gmtCreate":1637328918193,"gmtModify":1637328919371,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876590686","repostId":"1144455380","repostType":4,"repost":{"id":"1144455380","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637328728,"share":"https://www.laohunote.com/m/news/1144455380?lang=zh_CN&edition=full","pubTime":"2021-11-19 21:32","market":"us","language":"en","title":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1144455380","media":"Tiger Newspress","summary":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S","content":"<p>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和 BioNTech SE 的股价在盘前交易中上涨约 2%，此前它们获得了美国 FDA 扩大的加强剂紧急使用授权，将 18 岁及以上的个人包括在内。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），将18岁及以上的个人包括在内。加强剂量应在初级系列完成后至少六个月施用，剂量强度与初级系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>“辉瑞公司董事长兼首席执行官阿尔伯特-布尔拉（Albert Bourla）说：”随着我们抗击 COVID-19 的两年大关接近，我们又达到了一个重要的里程碑，扩大了 18 岁及以上人群接种 COVID-19 疫苗加强剂量的授权。“有了加强剂，更多的成年人现在将有机会帮助保持对这种疾病的高水平保护。我们感谢美国食品及药物管理局的严格审查，我们希望今天采取的行动将有助于加快我们摆脱这一大流行病的步伐。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>“BioNTech公司首席执行官兼联合创始人、医学博士乌古尔-沙欣（Ugur Sahin）说：”今天美国食品和药物管理局的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后会产生强劲的免疫反应，甚至超过了高效的两剂初级接种方案完成后的免疫反应。“这些数据表明，我们疫苗的加强剂量有可能对包括德尔塔在内的测试变种保持高水平的保护”。</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10 月，两家公司宣布了该试验的积极顶线结果显示，与未接受加强剂的人相比，对先前接受辉瑞-BioNTech 初级两剂系列的个体施用的加强剂量显示出 95% 的相对疫苗效力。到目前为止，这些是任何随机对照新冠肺炎疫苗加强试验中披露的第一个也是唯一一个疗效数据。不良事件概况与疫苗的其他临床安全性数据大致一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在65岁及以上的个体、18至64岁的严重新冠肺炎高风险个体和18至64岁的个体中紧急使用。经常在机构或职业中接触新型冠状病毒的18至64岁的个体，以及已完成不同授权新冠肺炎疫苗初次接种的合格个体。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和 BioNTech 根据与美国政府的现有供应协议继续供应疫苗，包括足够数量的加强剂，该协议将持续到 2022 年 4 月。这些公司预计今天的消息不会影响与世界各国政府和国际卫生组织现有的供应协议。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer and BioNTech SE stocks climbed about 2% in premarket trading<blockquote>辉瑞和 BioNTech SE 股票在盘前交易中上涨约 2%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-11-19 21:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.</p><p><blockquote>辉瑞和 BioNTech SE 的股价在盘前交易中上涨约 2%，此前它们获得了美国 FDA 扩大的加强剂紧急使用授权，将 18 岁及以上的个人包括在内。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/a0ee0544027cc35ceeb2a44c7caf0848\" tg-width=\"850\" tg-height=\"619\" width=\"100%\" height=\"auto\"><img src=\"https://static.tigerbbs.com/026143e67c4e4f63fadd07b9b23e1301\" tg-width=\"850\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Pfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.</p><p><blockquote>辉瑞公司和BioNTech SE今天宣布，美国。美国食品药品监督管理局（FDA）已经扩大了辉瑞-BioNTech新冠肺炎疫苗加强剂量的紧急使用授权（EUA），将18岁及以上的个人包括在内。加强剂量应在初级系列完成后至少六个月施用，剂量强度与初级系列中的剂量相同。</blockquote></p><p> “As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p><p><blockquote>“辉瑞公司董事长兼首席执行官阿尔伯特-布尔拉（Albert Bourla）说：”随着我们抗击 COVID-19 的两年大关接近，我们又达到了一个重要的里程碑，扩大了 18 岁及以上人群接种 COVID-19 疫苗加强剂量的授权。“有了加强剂，更多的成年人现在将有机会帮助保持对这种疾病的高水平保护。我们感谢美国食品及药物管理局的严格审查，我们希望今天采取的行动将有助于加快我们摆脱这一大流行病的步伐。”</blockquote></p><p> “Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”</p><p><blockquote>“BioNTech公司首席执行官兼联合创始人、医学博士乌古尔-沙欣（Ugur Sahin）说：”今天美国食品和药物管理局的决定得到了临床数据的支持，这些数据显示，我们的疫苗加强剂量后会产生强劲的免疫反应，甚至超过了高效的两剂初级接种方案完成后的免疫反应。“这些数据表明，我们疫苗的加强剂量有可能对包括德尔塔在内的测试变种保持高水平的保护”。</blockquote></p><p> In October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.</p><p><blockquote>10 月，两家公司宣布了该试验的积极顶线结果显示，与未接受加强剂的人相比，对先前接受辉瑞-BioNTech 初级两剂系列的个体施用的加强剂量显示出 95% 的相对疫苗效力。到目前为止，这些是任何随机对照新冠肺炎疫苗加强试验中披露的第一个也是唯一一个疗效数据。不良事件概况与疫苗的其他临床安全性数据大致一致，未发现新的安全性问题。</blockquote></p><p> A booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.</p><p><blockquote>辉瑞-BioNTech新冠肺炎疫苗的加强剂量此前已被FDA授权在65岁及以上的个体、18至64岁的严重新冠肺炎高风险个体和18至64岁的个体中紧急使用。经常在机构或职业中接触新型冠状病毒的18至64岁的个体，以及已完成不同授权新冠肺炎疫苗初次接种的合格个体。</blockquote></p><p> Pfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.</p><p><blockquote>辉瑞和 BioNTech 根据与美国政府的现有供应协议继续供应疫苗，包括足够数量的加强剂，该协议将持续到 2022 年 4 月。这些公司预计今天的消息不会影响与世界各国政府和国际卫生组织现有的供应协议。</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144455380","content_text":"Pfizer and BioNTech SE stocks climbed about 2% in premarket trading after they received expanded U.S. FDA emergency use authorization of booster to include individuals 18 and older.\n\nPfizer Inc. and BioNTech SE today announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years of age and older. The booster dose is to be administered at least six months after completion of the primary series, and is the same dosage strength as the doses in the primary series.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\n“Today’s FDA decision is supported by clinical data showing robust immune responses following a booster dose of our vaccine, exceeding what has been seen even after the completion of the highly-effective two-dose primary schedule,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “These data suggest a booster dose of our vaccine has the potential to maintain a high-level of protection against tested variants, including Delta.”\nIn October, the companies announced positive topline results from the trial showing that a booster dose administered to individuals who previously received the Pfizer-BioNTech primary two-dose series demonstrated a relative vaccine efficacy of 95% when compared to those who did not receive a booster. Thus far, these are the first and only efficacy data disclosed from any randomized, controlled COVID-19 vaccine booster trial. The adverse event profile was generally consistent with other clinical safety data for the vaccine, with no new safety concerns identified.\nA booster dose of the Pfizer-BioNTech COVID-19 Vaccine was previously authorized by the FDA for emergency use after completion of a primary series in individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2, as well as eligible individuals who have completed primary vaccination with a different authorized COVID-19 vaccine.\nPfizer and BioNTech continue to supply the vaccine, including sufficient volume for boosters, under their existing supply agreement with the U.S. government, which continues through April 2022. The companies do not expect that today’s news will impact the existing supply agreements in place with governments and international health organizations around the world.","news_type":1,"symbols_score_info":{"PFE":0.9,"BNTX":0.9}},"isVote":1,"tweetType":1,"viewCount":2283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878597951,"gmtCreate":1637204011642,"gmtModify":1637204011642,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Lets rock tonight","listText":"Lets rock tonight","text":"Lets rock tonight","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/878597951","repostId":"2184885073","repostType":2,"isVote":1,"tweetType":1,"viewCount":2751,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":836147492,"gmtCreate":1629467393216,"gmtModify":1633684639262,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Wtf","listText":"Wtf","text":"Wtf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/836147492","repostId":"1181270196","repostType":4,"repost":{"id":"1181270196","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629466972,"share":"https://www.laohunote.com/m/news/1181270196?lang=zh_CN&edition=full","pubTime":"2021-08-20 21:42","market":"us","language":"en","title":"Snowflake Drops Most in Five Months Amid Cautious Analyst Report By Esha Dey<blockquote>Esha Dey 发布谨慎的分析师报告，雪花降幅为五个月来最大</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1181270196","media":"Tiger Newspress","summary":"(Update: August 20, 2021 at 10:37 a.m. ET)\n(Aug 20) Snowflake shares drop as much as 11% on Friday, ","content":"<p><i><b>(Update: August 20, 2021 at 10:37 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间 2021 年 8 月 20 日上午 10:37）</b></i></blockquote></p><p> (Aug 20) Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.</p><p><blockquote>(8月20日）克利夫兰研究公司（Cleveland Research Graphic Dashboard）的一份报告称，该公司的签约增长从第一季度开始放缓，而消费增长最多可能与第一季度的水平相似，之后雪花股价周五下跌了11%，创下了美国股市自3月份以来的最大盘中跌幅。</blockquote></p><p> The report also said that the company’s partners were seeing sales cycles elongate on increased competition from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.</p><p><blockquote>报告还称，由于来自超大规模企业的竞争加剧，该公司的合作伙伴发现销售周期正在延长，尤其是谷歌的 BigQuery Cleveland 没有正式覆盖 SNOW，也没有投资意见。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/091af68dd7c59cce7e1b1f053df2d729\" tg-width=\"1572\" tg-height=\"718\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Snowflake Drops Most in Five Months Amid Cautious Analyst Report By Esha Dey<blockquote>Esha Dey 发布谨慎的分析师报告，雪花降幅为五个月来最大</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSnowflake Drops Most in Five Months Amid Cautious Analyst Report By Esha Dey<blockquote>Esha Dey 发布谨慎的分析师报告，雪花降幅为五个月来最大</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-08-20 21:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><i><b>(Update: August 20, 2021 at 10:37 a.m. ET)</b></i></p><p><blockquote><i><b>（更新：美国东部时间 2021 年 8 月 20 日上午 10:37）</b></i></blockquote></p><p> (Aug 20) Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.</p><p><blockquote>(8月20日）克利夫兰研究公司（Cleveland Research Graphic Dashboard）的一份报告称，该公司的签约增长从第一季度开始放缓，而消费增长最多可能与第一季度的水平相似，之后雪花股价周五下跌了11%，创下了美国股市自3月份以来的最大盘中跌幅。</blockquote></p><p> The report also said that the company’s partners were seeing sales cycles elongate on increased competition from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.</p><p><blockquote>报告还称，由于来自超大规模企业的竞争加剧，该公司的合作伙伴发现销售周期正在延长，尤其是谷歌的 BigQuery Cleveland 没有正式覆盖 SNOW，也没有投资意见。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/091af68dd7c59cce7e1b1f053df2d729\" tg-width=\"1572\" tg-height=\"718\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNOW":"Snowflake"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1181270196","content_text":"(Update: August 20, 2021 at 10:37 a.m. ET)\n(Aug 20) Snowflake shares drop as much as 11% on Friday, SNOW US Equity biggest intraday decline since March, after a Cleveland Research Graphic Dashboard» report said the company’s signings growth slowed from 1Q, while consumption growth was likely similar, at best, to 1Q levels.\nThe report also said that the company’s partners were seeing sales cycles elongate on increased competition from the hyperscalers, particularly Google’s BigQuery Cleveland does not formally cover SNOW and does not have an investment opinion.","news_type":1,"symbols_score_info":{"SNOW":0.9}},"isVote":1,"tweetType":1,"viewCount":2783,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147921660,"gmtCreate":1626328801950,"gmtModify":1633927802368,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Norm is earnings out SP drops but not sure about TSM","listText":"Norm is earnings out SP drops but not sure about TSM","text":"Norm is earnings out SP drops but not sure about TSM","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147921660","repostId":"1113252389","repostType":4,"repost":{"id":"1113252389","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626327337,"share":"https://www.laohunote.com/m/news/1113252389?lang=zh_CN&edition=full","pubTime":"2021-07-15 13:35","market":"us","language":"en","title":"TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>台积电第二季度利润因芯片需求强劲增长 11%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113252389","media":"Tiger Newspress","summary":"Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring ho","content":"<p><a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.</p><p><blockquote><a href=\"https://laohu8.com/S/TSM\">台积电</a>公司公布的季度利润增长了 11%，这凸显了该公司如何从全球芯片短缺中受益，全球芯片短缺推动了汽车和其他行业的订单增加。</blockquote></p><p> Net income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.</p><p><blockquote>截至 6 月的季度净利润升至新台币 1344 亿元（48 亿美元），略低于分析师平均预期的新台币 1361.5 亿元。根据之前公布的月度销售数据，营收为新台币3721.5亿元。</blockquote></p><p> While an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.</p><p><blockquote>虽然持续的半导体短缺阻碍了全球经济从 Covid-19 中复苏，但全球最大的合同芯片制造商台积电等供应商也是受益者之一，他们竞相完成订单。这家台湾公司也可能从计划中获得提升<a href=\"https://laohu8.com/S/AAPL\">苹果</a>其最大客户Inc.将在今年下半年准备9000万部升级版iPhone。</blockquote></p><p> “As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” <a href=\"https://laohu8.com/S/C\">Citigroup</a> analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”</p><p><blockquote>“由于台积电在未来几个季度可能会继续以极高的利用率装载产能，我们预计强劲的收入势头将持续到 2021 年底。”<a href=\"https://laohu8.com/S/C\">花旗集团</a>分析师罗兰·舒上周在一份报告中写道。“需求强劲，但供应链产能增长有限，将继续使台积电能够最大限度地利用其产能，并进一步增强其定价能力。”</blockquote></p><p> In early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.</p><p><blockquote>7月初，戴姆勒股份公司和捷豹路虎警告称，持续的芯片短缺将进一步削减销量，后者表示第二季度的交付量将比最初预期的差50%。5 月份英国经济增速放缓至 0.8%，部分原因是半导体短缺导致运输设备产量下滑 16.4%。</blockquote></p><p> <a href=\"https://laohu8.com/S/UMC\">United Microelectronics</a> Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.</p><p><blockquote><a href=\"https://laohu8.com/S/UMC\">联合微电子</a>台积电的规模较小的竞争对手Corp.上周表示，芯片需求可能会继续超过供应，直到2023年。</blockquote></p><p> In response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.</p><p><blockquote>为了响应汽车制造商的需求，台积电表示将增加对该行业的出货量。汽车客户的收入较第一季度增长了 12%，而高性能计算的收入也增长了类似的幅度。智能手机客户的销售额是其收入的最大组成部分，在季节性放缓的第二季度下降了 3%。</blockquote></p><p> Gross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.</p><p><blockquote>毛利率为 50%，低于分析师预测的约 51% 的平均水平。6 月初，台湾中部一家工厂发生聚集性 Covid-19 感染事件，迫使金源电子股份有限公司、<a href=\"https://laohu8.com/S/AONE\">一</a>世界领先的芯片测试服务提供商之一，将暂时关闭运营。这导致世界各地许多人所依赖的台湾半导体供应链出现轻微中断。台积电周一表示，该公司有三名员工被证实感染，但认为不会对运营造成任何影响。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8972f21d044da7c44c189d05e553355d\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul> <li>TSMC today announced consolidated <b>revenue of NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit)</b> for the second quarter ended June 30, 2021.</li> <li>Year-over-year, second quarter <b>revenue increased 19.8% while net income and diluted EPS both increased 11.2%.</b> Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</li> <li>In US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.</li> <li><b>Gross margin for the quarter was 50.0%,</b> operating margin was 39.1%, and net profit margin was 36.1%.</li> <li>In the second quarter, <b>shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%.</b> <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.</li> </ul> <img src=\"https://static.tigerbbs.com/3f1042154c2034c25d54d740e91d9a2e\" tg-width=\"658\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>台积电今天宣布合并<b>营收3721.5亿元，净利润1343.6亿元，每股摊薄盈利5.18元（每ADR单位0.93美元）</b>截至2021年6月30日的第二季度。</li><li>第二季度同比<b>收入增长 19.8%，净利润和稀释每股收益均增长 11.2%。</b>与2021年第一季度相比，第二季度业绩显示收入增长2.7%，净利润下降3.8%。所有数字均根据国际财务报告准则按综合基准编制。</li><li>以美元计，第二季度营收为132.9亿美元，同比增长28.0%，环比增长2.9%。</li><li><b>本季度毛利率为50.0%，</b>营业利润率为39.1%，净利润率为36.1%。</li><li>第二季度，<b>5纳米出货量占晶圆总收入的18%；7-纳米占31%。</b><a href=\"https://laohu8.com/S/AEIS\">先进的</a>技术（定义为 7 纳米和更先进的技术）占晶圆总收入的 49%。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>台积电第二季度利润因芯片需求强劲增长 11%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC’s Second-Quarter Profit Rises 11% on Strong Chip Demand<blockquote>台积电第二季度利润因芯片需求强劲增长 11%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-15 13:35</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.</p><p><blockquote><a href=\"https://laohu8.com/S/TSM\">台积电</a>公司公布的季度利润增长了 11%，这凸显了该公司如何从全球芯片短缺中受益，全球芯片短缺推动了汽车和其他行业的订单增加。</blockquote></p><p> Net income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.</p><p><blockquote>截至 6 月的季度净利润升至新台币 1344 亿元（48 亿美元），略低于分析师平均预期的新台币 1361.5 亿元。根据之前公布的月度销售数据，营收为新台币3721.5亿元。</blockquote></p><p> While an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.</p><p><blockquote>虽然持续的半导体短缺阻碍了全球经济从 Covid-19 中复苏，但全球最大的合同芯片制造商台积电等供应商也是受益者之一，他们竞相完成订单。这家台湾公司也可能从计划中获得提升<a href=\"https://laohu8.com/S/AAPL\">苹果</a>其最大客户Inc.将在今年下半年准备9000万部升级版iPhone。</blockquote></p><p> “As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” <a href=\"https://laohu8.com/S/C\">Citigroup</a> analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”</p><p><blockquote>“由于台积电在未来几个季度可能会继续以极高的利用率装载产能，我们预计强劲的收入势头将持续到 2021 年底。”<a href=\"https://laohu8.com/S/C\">花旗集团</a>分析师罗兰·舒上周在一份报告中写道。“需求强劲，但供应链产能增长有限，将继续使台积电能够最大限度地利用其产能，并进一步增强其定价能力。”</blockquote></p><p> In early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.</p><p><blockquote>7月初，戴姆勒股份公司和捷豹路虎警告称，持续的芯片短缺将进一步削减销量，后者表示第二季度的交付量将比最初预期的差50%。5 月份英国经济增速放缓至 0.8%，部分原因是半导体短缺导致运输设备产量下滑 16.4%。</blockquote></p><p> <a href=\"https://laohu8.com/S/UMC\">United Microelectronics</a> Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.</p><p><blockquote><a href=\"https://laohu8.com/S/UMC\">联合微电子</a>台积电的规模较小的竞争对手Corp.上周表示，芯片需求可能会继续超过供应，直到2023年。</blockquote></p><p> In response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.</p><p><blockquote>为了响应汽车制造商的需求，台积电表示将增加对该行业的出货量。汽车客户的收入较第一季度增长了 12%，而高性能计算的收入也增长了类似的幅度。智能手机客户的销售额是其收入的最大组成部分，在季节性放缓的第二季度下降了 3%。</blockquote></p><p> Gross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., <a href=\"https://laohu8.com/S/AONE\">one</a> of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.</p><p><blockquote>毛利率为 50%，低于分析师预测的约 51% 的平均水平。6 月初，台湾中部一家工厂发生聚集性 Covid-19 感染事件，迫使金源电子股份有限公司、<a href=\"https://laohu8.com/S/AONE\">一</a>世界领先的芯片测试服务提供商之一，将暂时关闭运营。这导致世界各地许多人所依赖的台湾半导体供应链出现轻微中断。台积电周一表示，该公司有三名员工被证实感染，但认为不会对运营造成任何影响。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8972f21d044da7c44c189d05e553355d\" tg-width=\"663\" tg-height=\"440\" referrerpolicy=\"no-referrer\"></p><p><blockquote></blockquote></p><p> <ul> <li>TSMC today announced consolidated <b>revenue of NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit)</b> for the second quarter ended June 30, 2021.</li> <li>Year-over-year, second quarter <b>revenue increased 19.8% while net income and diluted EPS both increased 11.2%.</b> Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.</li> <li>In US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.</li> <li><b>Gross margin for the quarter was 50.0%,</b> operating margin was 39.1%, and net profit margin was 36.1%.</li> <li>In the second quarter, <b>shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%.</b> <a href=\"https://laohu8.com/S/AEIS\">Advanced</a> technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.</li> </ul> <img src=\"https://static.tigerbbs.com/3f1042154c2034c25d54d740e91d9a2e\" tg-width=\"658\" tg-height=\"434\" referrerpolicy=\"no-referrer\"></p><p><blockquote><ul><li>台积电今天宣布合并<b>营收3721.5亿元，净利润1343.6亿元，每股摊薄盈利5.18元（每ADR单位0.93美元）</b>截至2021年6月30日的第二季度。</li><li>第二季度同比<b>收入增长 19.8%，净利润和稀释每股收益均增长 11.2%。</b>与2021年第一季度相比，第二季度业绩显示收入增长2.7%，净利润下降3.8%。所有数字均根据国际财务报告准则按综合基准编制。</li><li>以美元计，第二季度营收为132.9亿美元，同比增长28.0%，环比增长2.9%。</li><li><b>本季度毛利率为50.0%，</b>营业利润率为39.1%，净利润率为36.1%。</li><li>第二季度，<b>5纳米出货量占晶圆总收入的18%；7-纳米占31%。</b><a href=\"https://laohu8.com/S/AEIS\">先进的</a>技术（定义为 7 纳米和更先进的技术）占晶圆总收入的 49%。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113252389","content_text":"Taiwan Semiconductor Manufacturing Co. reported an 11% increase in quarterly profit, underscoring how the company has benefited from a global chip shortage that’s driven up orders from the automotive and other industries.\nNet income for the quarter ended in June rose to NT$134.4 billion ($4.8 billion), slightly below the average analyst estimate of NT$136.15 billion. Revenue came in at NT$372.15 billion based on previously released monthly sales figures.\nWhile an ongoing semiconductor shortage has hampered the global economic recovery from Covid-19, suppliers like TSMC, the world’s largest contract chipmaker, are among beneficiaries as they race to fulfill orders. The Taiwanese company is also likely to get a lift from plans by Apple Inc., its largest customer, to ready 90 million units of upgraded iPhones for the second half of this year.\n“As TSMC will likely keep loading its capacity at extremely high utilization in upcoming quarters, we expect the strong revenue momentum to continue through end of 2021,” Citigroup analyst Roland Shu wrote in a note last week. “Strong demand but limited capacity increases in the supply chain will continue to allow TSMC to best utilize its capacities and further strengthen its pricing power.”\nIn early July, Daimler AG and Jaguar Land Rover warned that sales will be further curtailed by the persistent chip shortage, with the latter saying deliveries in the second quarter will be 50% worse than initially thought. The U.K. economy’s growth slowed to 0.8% in May, partly due to a 16.4% slump in the production of transport equipment triggered by a lack of semiconductors.\nUnited Microelectronics Corp., a smaller rival to TSMC, said last week that chip demand could continue to outpace supply until 2023.\nIn response to the demand from carmakers, TSMC has said it will increase shipments to the sector. Revenue from automotive clients increased 12% from the first quarter, while high-performance computing climbed by a similar magnitude. Sales to smartphone clients, the biggest chunk of its revenue, eased 3% in the seasonally slower second quarter.\nGross margin was 50%, below the roughly 51% average predicted by analysts. In early June, a cluster of Covid-19 infections at a factory in central Taiwan forced King Yuan Electronics Co., one of the world’s leading chip-testing service providers, to shut operations temporarily. That led to minor disruptions in the Taiwanese semiconductor supply chain which many around the world rely on. TSMC said on Monday three of its employees were confirmed to have been infected, though it doesn’t see any impact on operations.\n\n\nTSMC today announced consolidated revenue of NT$372.15 billion, net income of NT$134.36 billion, and diluted earnings per share of NT$5.18(US$0.93 per ADR unit) for the second quarter ended June 30, 2021.\nYear-over-year, second quarter revenue increased 19.8% while net income and diluted EPS both increased 11.2%. Compared to first quarter 2021, second quarter results represented a 2.7% increase in revenue and a 3.8% decrease in net income. All figures were prepared in accordance with TIFRS on a consolidated basis.\nIn US dollars, second quarter revenue was $13.29 billion, which increased 28.0% year-over-year and increased 2.9% from the previous quarter.\nGross margin for the quarter was 50.0%, operating margin was 39.1%, and net profit margin was 36.1%.\nIn the second quarter, shipments of 5-nanometer accounted for 18% of total wafer revenue; 7- nanometer accounted for 31%. Advanced technologies, defined as 7-nanometer and more advanced technologies, accounted for 49% of total wafer revenue.","news_type":1,"symbols_score_info":{"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":1889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142755767,"gmtCreate":1626179721559,"gmtModify":1633929372871,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Good for financials","listText":"Good for financials","text":"Good for financials","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/142755767","repostId":"1162410134","repostType":4,"repost":{"id":"1162410134","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626179564,"share":"https://www.laohunote.com/m/news/1162410134?lang=zh_CN&edition=full","pubTime":"2021-07-13 20:32","market":"us","language":"en","title":"Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6 月份消费者价格指数上涨 5.4%，而预期为 5%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1162410134","media":"Tiger Newspress","summary":"Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor D","content":"<p>Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.</p><p><blockquote>美国劳工部周二报告称，6 月份通胀继续快速飙升，以近 13 年来最快的速度上升。</blockquote></p><p> The consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.</p><p><blockquote>消费者价格指数同比上涨5.4%，为金融危机前以来的最大涨幅。道琼斯调查的经济学家此前预计股价将上涨 5%。</blockquote></p><p> Stripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.</p><p><blockquote>剔除波动较大的食品和能源价格，核心 CPI 上涨 4.5%，为 1991 年 9 月以来该指标的最大涨幅，远高于 3.8% 的预期。</blockquote></p><p> Inflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.</p><p><blockquote>由于多种因素，通货膨胀一直在上升，包括供应链瓶颈、随着 Covid-19 大流行的缓解而异常高的需求，以及与危机最初几个月经济难以重新开放的时期的同比相比。</blockquote></p><p> Policymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.</p><p><blockquote>美联储和白宫的政策制定者预计当前的压力将开始缓解，尽管央行官员已经承认通胀比他们预期的更强劲，也可能更持久。</blockquote></p><p> Much of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.</p><p><blockquote>大部分价格压力来自受停工影响特别大的行业——二手车价格、机票和运输成本等等。</blockquote></p><p> However, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.</p><p><blockquote>然而，住房和住房价格继续攀升，加剧了通货膨胀可能会持续一段时间的信念。</blockquote></p><p> Consumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that</p><p><blockquote>纽约联储周一发布的一项调查显示，消费者预计未来 12 个月物价总体将上涨 4.8%，不过美国银行周二发布的另一项调查显示，</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Consumer price index increases 5.4% in June vs. 5% estimate<blockquote>6 月份消费者价格指数上涨 5.4%，而预期为 5%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConsumer price index increases 5.4% in June vs. 5% estimate<blockquote>6 月份消费者价格指数上涨 5.4%，而预期为 5%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-13 20:32</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.</p><p><blockquote>美国劳工部周二报告称，6 月份通胀继续快速飙升，以近 13 年来最快的速度上升。</blockquote></p><p> The consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.</p><p><blockquote>消费者价格指数同比上涨5.4%，为金融危机前以来的最大涨幅。道琼斯调查的经济学家此前预计股价将上涨 5%。</blockquote></p><p> Stripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.</p><p><blockquote>剔除波动较大的食品和能源价格，核心 CPI 上涨 4.5%，为 1991 年 9 月以来该指标的最大涨幅，远高于 3.8% 的预期。</blockquote></p><p> Inflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.</p><p><blockquote>由于多种因素，通货膨胀一直在上升，包括供应链瓶颈、随着 Covid-19 大流行的缓解而异常高的需求，以及与危机最初几个月经济难以重新开放的时期的同比相比。</blockquote></p><p> Policymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.</p><p><blockquote>美联储和白宫的政策制定者预计当前的压力将开始缓解，尽管央行官员已经承认通胀比他们预期的更强劲，也可能更持久。</blockquote></p><p> Much of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.</p><p><blockquote>大部分价格压力来自受停工影响特别大的行业——二手车价格、机票和运输成本等等。</blockquote></p><p> However, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.</p><p><blockquote>然而，住房和住房价格继续攀升，加剧了通货膨胀可能会持续一段时间的信念。</blockquote></p><p> Consumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that</p><p><blockquote>纽约联储周一发布的一项调查显示，消费者预计未来 12 个月物价总体将上涨 4.8%，不过美国银行周二发布的另一项调查显示，</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162410134","content_text":"Inflation continued its rapid surge in June, rising its fastest pace in nearly 13 years, the Labor Department reported Tuesday.\nThe consumer price index increased 5.4% from a year ago, the largest jump since just before the financial crisis. Economists surveyed by Dow Jones had been expecting a 5% gain.\nStripping out volatile food and energy prices, the core CPI rose 4.5%, the sharpest move for that measure since September 1991 and well above the estimate of 3.8%.\nInflation has been rising due to a number of factors, including supply chain bottlenecks, extraordinarily high demand as the Covid-19 pandemic eases, and year-over-year comparisons to a time when the economy was struggling to reopen in the early months of the crisis.\nPolicymakers at the Federal Reserve and the White House expect the current pressures to begin to ease, though central bank officials have acknowledged that inflation is stronger and perhaps more durable than they had anticipated.\nMuch of the price pressures have come from sectors particularly influenced by the shutdown – used car prices, air fares and transportation costs, to name three.\nHowever, housing and shelter prices continue to climb, adding fuel to the belief that inflation could stick around for a while.\nConsumers see prices overall up 4.8% in the next 12 months, according to a New York Fed survey released Monday, though a separate survey from Bank of America out Tuesday indicated that","news_type":1,"symbols_score_info":{".DJI":0.9,".IXIC":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1968,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":154321641,"gmtCreate":1625482293784,"gmtModify":1633940318766,"author":{"id":"3565499732569971","authorId":"3565499732569971","name":"Lamie","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3565499732569971","authorIdStr":"3565499732569971"},"themes":[],"title":"","htmlText":"Let them short","listText":"Let them short","text":"Let them short","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/154321641","repostId":"1199383023","repostType":4,"repost":{"id":"1199383023","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1625234763,"share":"https://www.laohunote.com/m/news/1199383023?lang=zh_CN&edition=full","pubTime":"2021-07-02 22:06","market":"us","language":"en","title":"Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1199383023","media":"Tiger Newspress","summary":"Iceberg Research, a short seller,said they're shorting AMC Entertainment.\nAMC stock tumbled 10% in F","content":"<p>Iceberg Research, a short seller,said they're shorting AMC Entertainment.</p><p><blockquote>卖空者冰山研究公司表示，他们正在做空AMC院线。</blockquote></p><p> AMC stock tumbled 10% in Friday morning trading.</p><p><blockquote>AMC 股价在周五早盘交易中暴跌 10%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fcd7b7275c61489d2f5ef4c91a74765\" tg-width=\"840\" tg-height=\"470\"></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Iceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIceberg Research: We're shorting AMC Entertainment<blockquote>冰山研究：我们正在做空AMC院线</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-07-02 22:06</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Iceberg Research, a short seller,said they're shorting AMC Entertainment.</p><p><blockquote>卖空者冰山研究公司表示，他们正在做空AMC院线。</blockquote></p><p> AMC stock tumbled 10% in Friday morning trading.</p><p><blockquote>AMC 股价在周五早盘交易中暴跌 10%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/8fcd7b7275c61489d2f5ef4c91a74765\" tg-width=\"840\" tg-height=\"470\"></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199383023","content_text":"Iceberg Research, a short seller,said they're shorting AMC Entertainment.\nAMC stock tumbled 10% in Friday morning trading.","news_type":1,"symbols_score_info":{"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":1810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}